MarketsandMarkets Virtual conference on Point-of-care Technology ( Time Zone - EASTERN STANDARD TIME (EST)

28th -29th September 2020
CONFERENCE SPEAKERS
Speakers
Kevin Wang
Kevin Wang
Director, Program for Neuroproteomics and Biomarkers Research,
University of Florida


Dr. Kevin Wang is the Director of the Program for NNBR and Associate Professor of Emergency Medicine at the University of Florida in USA.  Dr. Wang is a neurotrauma researcher since the late 1990’s. He has served as President and Council Member of the National Neurotrauma society, Board Member, Board of Governors of the International Brain Injury Association and Presidium Member of the Academy for Multidisciplinary Neurotraumatology. He is a co-founder of a biotechnology company Gryphon Bio, Inc. His research focus is translational research for biomarkers and therapies for traumatic brain injury (TBI), spinal cord injury, post-traumatic epilepsy, and chronic traumatic encephalopathy.  Two acute TBI blood-based protein biomarkers (UCH-L1/GFAP) he co-discovered have received FDA clearance as the first in vitro diagnostic tests for detecting pathoanatomical lesions in TBI patients. He also holds leadership positions on various TBI initiative such as International TBI Research Initiative (InTBIR), and multicenter TBI consortium studies (e.g. TRACK-TBI, CENTER-TBI, ICON-TBI).


 Alan H.B. Wu, Ph.D., DABACC
Alan H.B. Wu, Ph.D., DABACC
Chief of Clinical Chemistry and Toxicology,
San Francisco, General Hospital



 Dr. Jens Ducree
Dr. Jens Ducree
Professors of Microsystems in the School of Physical Sciences, ,
Dublin City University (DCU)



 Kevin Oliver
Kevin Oliver
Manager Respiratory Sleep, Neurodiagnostic, and Point of Care Testing,
HSHS St Elizabeth’s Hospital



  Dr. Aruna Korlimarla
Dr. Aruna Korlimarla
Assistant Professor, Division of Molecular Medicine,
St. John’s Research Institute, Bangalore, India